ABHP ADVOCACY TO PROTECT 340B DRUG PRICING PROGRAM
Section 340B of the Public Health Service Act (Pub. L. 102-585) requires participating drug manufacturers to provide discounted prices on covered outpatient drugs, to eligible healthcare organizations known as covered entities, who serves the country’s indigent and vulnerable patient population. The intent of the program is to permit covered entities to stretch scare federal resources as far as possible, reaching more eligible patients and providing more comprehensive health services. Covered entities realize significant savings by purchasing outpatient drugs through the 340B program. Covered entities use these savings to provide additional services that will benefit patients. The 340B program helps safety-net providers carry out their missions to serve their communities.
Dr. Paul C. Walker is the ABHP 2022 Wendell T. Hill Award Recipient
Dr. Walker is the current president of the American Society of Health-system Pharmacists (ASHP). He is Assistant Dean of Experiential Education and Community Engagement and Clinical Professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy, and Manager of Pharmacy Patient Outcomes in the Department of Pharmacy Services at Michigan Medicine. He received his BS in pharmacy and his PharmD from Wayne State University, in Detroit, and completed his residency in pharmacy practice at Children’s Hospital of Michigan, Detroit Medical Center. He also completed a specialty residency in pediatric pharmacy practice at the University of Tennessee and Le Bonheur Children’s Medical Center, Memphis, Tenn.
Dr. Angela Massey-Hill is the 2022 ASHP-ABHP Joint Leadership Award Recipient
Dr. Hill, Professor & Associate Dean of Clinical Affairs, at the University of South Florida, Taneja College of Pharmacy is the recipient of the 2022 ASHP-ABHP Joint Leadership Award. Dr. Hill is a respected educator, researcher, and leader with a passion for reducing racial and ethnic disparities in healthcare and fostering a more diverse and culturally literate healthcare workforce. Throughout her career, she has leveraged her vast expertise and community relationships to train investigators to implement culturally tailored strategies for enhancing the recruitment and retention of diverse research participants, mentor the next generation of cross-culturally informed and responsive patient care providers, and ensure intercultural competent pharmacist care is available and utilized both locally and globally.
Remembering the Early Defunct African American Pharmacy Schools
Celebrate Black History
The emergence of the early African American pharmacy schools ran parallel with the healthcare crisis created at the end of the Civil War where the deaths among newly emancipated African Americans were twice that of whites from the 1870s into the 1890s. The timeline also ran parallel with the period of post-Civil War Reconstruction and the enforcement of “Jim Crow” laws. To produce African American healthcare providers for the purpose of providing health care to their communities, separate African American medical and pharmacy schools evolved. Nine pharmacy programs were established for the training of African Americans between 1868 and 1927.
Celebrate the History of Black Pharmacists
Matilda Lloyd, Ella E. Coleman, and Margaret A. Miller are the first known African American females to be awarded pharmacy degrees in the U.S. They received the Graduate in Pharmacy (Ph.G.) degree in 1894 at Meharry Pharmaceutical College and it was also the first time that three African American women graduated in the same class in a pharmacy program in the U.S. After graduation, Matilda Lloyd was employed as a member of the faculty at Central Tennessee College in 1898 and later joined the executive staff at the Meharry Pharmaceutical College as Assistant Registrar, where she remained for more than 40 years.
Sign up to our newsletter and stay up to date